Literature DB >> 21586722

Personalizing evidence-based primary prevention with aspirin: individualized risks and patient preference.

David M Kent, Nilay D Shah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21586722      PMCID： PMC3108244          DOI： 10.1161/CIRCOUTCOMES.111.961136

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  17 in total

Review 1.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Authors:  Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

2.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

3.  Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.

Authors:  P M Ravdin; I A Siminoff; J A Harvey
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

4.  How patients with diabetes perceive their risk for major complications.

Authors:  D Meltzer; B Egleston
Journal:  Eff Clin Pract       Date:  2000 Jan-Feb

Review 5.  Design features of graphs in health risk communication: a systematic review.

Authors:  Jessica S Ancker; Yalini Senathirajah; Rita Kukafka; Justin B Starren
Journal:  J Am Med Inform Assoc       Date:  2006-08-23       Impact factor: 4.497

6.  How do patients perceive the benefits and risks of peripheral angioplasty? Implications for informed consent.

Authors:  Said B Habib; Luke Sonoda; Teik C See; Peter J Ell; Ashley M Groves
Journal:  J Vasc Interv Radiol       Date:  2008-02       Impact factor: 3.464

7.  The impact of high-risk patients on the results of clinical trials.

Authors:  J P Ioannidis; J Lau
Journal:  J Clin Epidemiol       Date:  1997-10       Impact factor: 6.437

8.  Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease.

Authors:  Corey A Siegel; L Campbell Levy; Todd A Mackenzie; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2008-01       Impact factor: 5.325

9.  Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.

Authors:  Audrey J Weymiller; Victor M Montori; Lesley A Jones; Amiram Gafni; Gordon H Guyatt; Sandra C Bryant; Teresa J H Christianson; Rebecca J Mullan; Steven A Smith
Journal:  Arch Intern Med       Date:  2007-05-28

10.  A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial.

Authors:  Michael R Nannenga; Victor M Montori; Audrey J Weymiller; Steven A Smith; Teresa J H Christianson; Sandra C Bryant; Amiram Gafni; Cathy Charles; Rebecca J Mullan; Lesley A Jones; Enrique R Bolona; Gordon H Guyatt
Journal:  Health Expect       Date:  2009-03       Impact factor: 3.377
View more
  3 in total

Review 1.  Acetylsalicylic acid/esomeprazole fixed-dose combination.

Authors:  Celeste B Burness; Lesley J Scott
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

2.  Patient-Centered Decision Support: Formative Usability Evaluation of Integrated Clinical Decision Support With a Patient Decision Aid for Minor Head Injury in the Emergency Department.

Authors:  Edward R Melnick; Erik P Hess; George Guo; Maggie Breslin; Kevin Lopez; Anthony J Pavlo; Fuad Abujarad; Seth M Powsner; Lori A Post
Journal:  J Med Internet Res       Date:  2017-05-19       Impact factor: 5.428

3.  Shared decision making in patients with stable coronary artery disease: PCI choice.

Authors:  Megan Coylewright; Kathy Shepel; Annie Leblanc; Laurie Pencille; Erik Hess; Nilay Shah; Victor M Montori; Henry H Ting
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.